Skip to content

APOTHEEK OPSOMER

Active Private limited companyfounded 2001active for 25 yearsGarenstraat 17, 8970 PoperingeKBO/BCE: BE 0474.919.225

Lifetime

19 annual accounts with figures on one time axis, 24 filings since 2002
peak of €690,905 in 2022
€215,724▼ 33.6%
peak of €335,233 in 2022
€27,726▼ 62.9%
peak of €1.0m in 2025
€1.0m▲ 2.7%
€175,343▼ 35.5%
peak of 3.7 FTE in 2022
2.3 FTE▼ 28.1%
Board1 name since 2022
1 director
Documentsfilings and deeds
23-01-20268 days before the deadline
2025abbreviated format
Gross margin from €324,757 to €215,724Result from €74,745 to €27,726Staff from 3.2 FTE to 2.3 FTEDebts from €271,763 to €175,343

Key points

from the 2025 annual accounts

Equity

€1.0m ▲ 2.7%

APOTHEEK OPSOMER has made a profit in every financial year since 2007.

Filings

24 annual accounts since 2002
deadline20102020

The last five annual accounts were filed 4 to 32 days before the end of the period.

Position in the sector

85.6%

Higher solvency than 93% of companies in retail trade. The sector median is 36.8%, over 13,303 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,048 companies had the same profile as APOTHEEK OPSOMER has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,048 companies, not a prediction for APOTHEEK OPSOMER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • deed of 24-07-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0474919225
appointed as director “Het oprichten, overnemen en uitbaten van een apotheek of apotheken met alle hieronder inbegrepen activiteiten…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 15-04-2022 · Gazette deed
Registered office moved within Poperinge The registered office moved from Vlamingstraat 9, 8970 Poperinge to Garenstraat 17, 8970 Poperinge · Board meeting of 09-08-2021 · Gazette deed
Capital increase of €312,300 to €342,300 The capital rose from €30,000 to €342,300 · Contribution by · General meeting of 30-06-2014 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK OPSOMER Poperinge €1.2m €215,724 85.6% 2.3
APOTHEEK DEHOUCK Ostend €1.2m €225,176 41.0% 2.2
Apotheek Ampe Middelkerke Middelkerke €1.2m €265,426 47.3% 2.2
Apotheek Melkmarkt Antwerp €1.1m €228,728 76.8% 2
APOTHEEK WELLENS Herentals €1.2m €270,551 38.8% 2.4
APOTHEEK I. DE BAUW Putte €1.1m €264,963 80.4% 2.3
APOTHEEK AERNOUTS Beerse €1.0m €233,229 70.3% 2.6

These companies have the same main activity as APOTHEEK OPSOMER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.2m, founded between 1996 and 2006.

Official details

Source: KBO
Status
Active since 31-05-2001Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 30-06-2025
Establishment unit
2.095.191.1898970 Poperinge, since 25-09-2001
Financial year end
30 June
Peppol
Reachable since 28-05-2025
Company details

Annual accounts to 30-06-2025

≈ €1.0mestimated
€1.2m▼ 5.4%
Employeeson 30-06-2025
4=
Filing
Filed on 23-01-2026, 8 days before the end of the filing period
Financials

Insights on APOTHEEK OPSOMER

APOTHEEK OPSOMER files the abbreviated format. That format states no turnover. The gross margin rose from €209,358 in 2007 to €215,724 in 2025.

The balance sheet grew most from 2017 to 2019 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK OPSOMER

What is the company number of APOTHEEK OPSOMER?
The company number of APOTHEEK OPSOMER is 0474.919.225. The VAT number is the same number with BE in front: BE 0474.919.225.
Where is APOTHEEK OPSOMER based?
The registered office is at Garenstraat 17, 8970 Poperinge.Company details
What does APOTHEEK OPSOMER do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK OPSOMER?
APOTHEEK OPSOMER is a private limited company (BV).
When was APOTHEEK OPSOMER founded?
APOTHEEK OPSOMER was founded on 31-05-2001.
Is APOTHEEK OPSOMER still active?
Yes, APOTHEEK OPSOMER is an active enterprise in the KBO register.
How many employees does APOTHEEK OPSOMER have?
APOTHEEK OPSOMER had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK OPSOMER fall under?
In its 30-06-2025 annual accounts, APOTHEEK OPSOMER states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK OPSOMER?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €215,724 and 43 comparable companies (NACE 477). It probably lies between €660,000 and €2.1m.
Is APOTHEEK OPSOMER profitable?
In financial year 2025, APOTHEEK OPSOMER made a profit of €27,726.
Where can I find the annual accounts of APOTHEEK OPSOMER?
APOTHEEK OPSOMER filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK OPSOMER due?
APOTHEEK OPSOMER must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.